As many as 5,000 women a year with hormone-sensitive breast cancer could benefit

Karen Bonham was part of successful trial for genomic test that determines which women with breast cancer can safely avoid chemotherapy

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes

Doctors said the test shows people with certain forms of the disease can safely avoid chemotherapy

As many as 5,000 women a year with hormone-sensitive breast cancer could benefit

Un ensayo clínico con miles de participantes cambió lo que se sabía sobre un tratamiento habitual.Los resultados sorprendieron incluso a los investigadores que diseñaron el…

A DNA‑based test of the tumour can help two‑thirds of certain breast cancer patients safely avoid chemotherapy without significantly compromising their long-term outcomes